Largest Taiwanese (TAIEX) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED May 09, 2025

Discover large cap Taiwanese Pharmaceuticals & Biotech companies that are on the TAIEX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

131 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
6446
PharmaEssentia
NT$515.00-4.3%64.8%NT$171.5bNT$700.50PE57.8xE59.8%0.2%
6919
Caliway Biopharmaceuticals
NT$715.001.1%88.7%NT$110.5bNT$930.00PS2487.9xE109.9%n/a
6472
Bora Pharmaceuticals
NT$719.000%0.8%NT$74.2bNT$963.50PE18.8xE12.4%1.9%
1795
Lotus Pharmaceutical
NT$229.000.7%-20.3%NT$60.0bNT$368.00PE11.9xE4.1%2.5%
6550
Polaris Group
NT$43.0516.7%-38.6%NT$33.2bn/aPS309.9xn/an/a
4743
Oneness Biotech
NT$59.10-3.3%-59.4%NT$28.3bNT$308.00PS239.7xn/a0%
6535
Lumosa Therapeutics
NT$157.00-5.7%-17.2%NT$26.5bNT$230.00PS608.4xn/an/a
4123
Center Laboratories
NT$35.65-1.8%-20.9%NT$25.7bn/aPS15.9xn/a2.1%
4728
Sunmax Biotechnology
NT$466.50-5.7%91.6%NT$25.4bn/aPE37.4xn/a2.5%
4147
TaiMed Biologics
NT$79.50-2.7%-8.1%NT$21.7bNT$141.67PS35.6xE32.9%n/a
4105
TTY Biopharm
NT$76.20-1.3%-2.8%NT$18.9bNT$78.00PE13.1xn/a5.5%
6589
EirGenix
NT$61.90-2.4%-22.5%NT$18.9bNT$127.50PS18.7xE26.3%n/a
3705
YungShin Global Holding
NT$68.203.8%32.9%NT$18.2bn/aPE14.8xn/a3.4%
6547
Medigen Vaccine Biologics
NT$49.80-7.9%-7.9%NT$16.4bNT$102.00PS27xn/an/a
1789
ScinoPharm Taiwan
NT$19.050.5%-30.9%NT$15.1bNT$24.00PE61.4xn/a1.8%
4114
Synmosa Biopharma
NT$32.700.6%-9.1%NT$14.9bn/aPE21.7xn/a1.7%
6541
Tanvex BioPharma
NT$58.20-4.1%35.3%NT$13.9bn/aPS400.3xn/an/a
6712
Ever Supreme Bio Technology
NT$163.00-0.3%-10.6%NT$13.0bNT$230.00PE35.5xE16.8%3.1%
4162
PharmaEngine
NT$90.500.9%-3.0%NT$13.0bNT$120.00PE7.4xn/a6.6%
6617
Gongwin Biopharm Holdings
NT$101.002.7%-46.1%NT$12.7bn/aPS397.4xn/an/a
6620
Handa Pharmaceuticals
NT$77.303.1%-44.4%NT$12.2bNT$200.00PE27xn/a1.3%
1720
Standard Chemical & Pharmaceutical
NT$59.601.0%-11.6%NT$10.7bNT$73.00PE12.1xn/a4.7%
6976
Acepodia
NT$17.70-1.7%-37.9%NT$10.3bn/aPS24063.1xn/an/a
4174
OBI Pharma
NT$38.65-2.8%-37.4%NT$10.2bn/aPS162.2xn/an/a
Page 1 of 6